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Abstract 
Objectives: To evaluate the expression of COX-2, E-cadherin, vimentin, 14-3-3σ, and 
PTEN tumor-related proteins in equine penile papillomas (ePP) and squamous cell 
carcinomas (ePSCC), the occurrence of epithelial-mesenchymal transition (EMT) at 
the invasion front (IF) and compare our findings with current knowledge on human 
penile squamous cell carcinoma (hPSCC).  
Material and Methods: We analyzed, by immunohistochemistry in 45 penile 
proliferative epithelial lesions, the expression of COX-2, E-cadherin, vimentin, 14-3-
3σ, and PTEN using monoclonal antibodies. Tumors were histopathologically 
classified as well-differentiated or poorly-differentiated using the IF grading scheme. 
Semiquantitative analysis was performed to determine down or up-regulation of the 
proteins and association with histopathological characteristics were statistically 
investigated using Mann-Whitney U test and/or Spearman’s tests.  
Results: COX-2 was neo-expressed in 86.6% of the cases and expression 
progressively increased from ePP to ePSCC (p=0.0003) and from well to poorly-
differentiated (p=0.033). High COX-2 expression was associated with a high mitotic 
index (MI) (p=0.026). In contrast to normal epidermis, ePSCC had very low E-cadherin 
expression in 64% of the cases (p=0.0005). Vimentin was neo-expressed in 65% of 
poorly-differentiated ePSCC at the IF indicating EMT. Cytoplasmic 14-3-3σ protein 
expression was reduced in 42% of the ePSCC and additionally, nuclear expression of 
14-3-3σ in neoplastic keratinocytes and in the cytoplasm of stromal fibroblasts at the 
IF were features only found in ePSCC. PTEN protein showed a tendency to be 
decreased or lost in ePSCC. 
Conclusions: Our study provides evidence of molecular abnormalities in ePSCC 
similar to those reported for human PSCC. The occurrence of EMT at the IF is a 
common event in ePSCC. Naturally-occurring ePSCC could serve as a valuable 
preclinical animal model to explore upcoming therapeutic options for hPSCC. 
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1. Introduction 
Human penile cancer is a rare disease in developed countries with an incidence rate 
of around 1 per 100,000 [1]. In contrast, it is more common in developing countries 
accounting for up to 10-17% of cancer in males with an incidence that reaches 4 per 
100,000 [1, 2]. Squamous cell carcinoma (SCC) is the predominant cancer type and 
accounts for over 95% of penile cancer cases [3-5]. The main treatment for advanced 
tumors is phalectomy and, when inguinal lymph node metastasis is present, bilateral 
inguinal lymphadenectomy is also performed. These procedures are associated with 
high psychological morbidity and negatively impact the quality of life of affected 
patients [4]. In the UK, it is reported that there has been an increase in incidence of 
approximately 25% since 1985 [6, 7]. The pathogenesis of human penile SCC 
(hPSCC) remains unclear; lack of circumcision, phimosis, cigarette-smoking and 
obesity have been widely discussed as potentially contributing to its development. The 
hypothesis of a bimodal pathogenesis of hPSCC is accepted, with human 
papillomavirus- (HPV) and non-HPV-related cases. HPV infection plays a role in 
hPSCC carcinogenesis and high-risk HPV-DNA is present in 12% to 72% of cancers 
[7].   
As a result of its rarity, most treatment options are based on the results of small clinical 
trials. Experimental models for human diseases, including in vitro studies using cancer 
cell lines, and animal models using non-spontaneous/induced tumors or xenografts, 
are valuable resources in biomedical research when evaluating new potential 
therapies [8]. However, these models have limitations and often they do not resemble 
morphologically, or at the molecular level, the disease in humans. Currently, there is 
a lack of commercially available hPSCC cell lines and no reliable xenograft models 
have been produced [9]. 
In humans, a variety of proteins involved in hPSCC have been studied and associated 
with pathological features and prognosis. Overexpression of the enzyme COX-2 is 
associated with proliferation, angiogenesis, invasion and metastasis [10, 11]. 
Phosphatase and tensin homolog (PTEN), a tumor suppressor gene, is frequently 
mutated in many cancers, including hPSCC, leading to reduced production of its 
transcription product, PTEN protein, which holds important functions preventing cell 
proliferation [12]. E-cadherin and vimentin are proteins associated with the epithelial-
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mesenchymal transition (EMT) process, which have been associated with a poorer 
prognosis [13, 14]. Additionally, 14-3-3σ is an oncoprotein that promotes cell 
proliferation, survival, invasiveness, metastasis and chemoresistance by binding and 
modulating various molecular pathways in vulvar, cervical and head and neck SCC 
[15-18].  
Naturally occurring tumors in domestic animals represent a unique opportunity to study 
cancer in vivo. Yet, few studies have been done to establish a specific animal cancer 
as a model for its human counterpart [8]. SCC is the most common penile neoplasm 
in the horse and a novel type of equine papillomavirus (EcPV-2) is suggested to play 
a role as initiator in this cancer, acting in a similar way to high-risk HPV-16 in humans 
[19]. Currently, there is a significant paucity of knowledge on the molecular events 
leading to the initiation and progression of PSCC in the horse and, given the clinical 
and biological similarities with hPSCC, we hypothesize they could share similar protein 
aberrations and altered molecular mechanisms, particularly EMT. Equine PSCC 
(ePSCC) could therefore serve as a highly relevant spontaneous animal model in the 
context of translational research.  
The objectives of this study were to analyze the expression of COX-2, 14-3-3σ, E-
cadherin, vimentin and PTEN proteins in equine penile papilloma (ePP) and ePSCC 
and compare their expression with histopathological features and in comparison with 
hPSCC. Furthermore, we aimed to analyze the occurrence of EMT by examining E-
cadherin and vimentin expression. 
 
2. Methods 
2.1. Cases and histological assessment 
A search in the database of the Diagnostic Pathology Service of the Royal Veterinary 
College and the University of Bristol was performed using the following key words; 
‘equine’, ‘papilloma’ and ‘squamous cell carcinoma’. A total of 58 cases were 
identified. Epithelial proliferative lesions from the skin, ocular or vulvar regions were 
excluded and finally a total of 45 cases of ePP or ePSCC were selected. Hematoxylin 
and eosin archived tissue sections were available and were re-examined by two 
veterinary pathologists (ASB and SLP). The neoplasms were analyzed in both the core 
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and at the invasive front (IF) (defined as the deepest area of the tumor and the 
boundary between the infiltrating neoplastic cells and the dermis). Histological 
examination, using a modified two-tier grading system based on the Bryne system,  
classified ePSCC as either well-differentiated or poorly-differentiated (Table 1) [20]. 
The presence of vascular invasion (presence of neoplastic cells within lymphatic or 
blood vessels) was also investigated. Clinical follow-up data was available for 6 cases. 
Table 1. Invasive Front Grading System for use in equine penile squamous cell 
carcinoma* 
  Score   
Morphological 
Feature 
1 2 3 4 
Degree of 
keratinization 
Highly keratinized 
(>50% of cells) 
Moderately 
keratinized 
(20–50% of cells) 
Minimal keratinization 
(5–20% of cells) 
No keratinization 
(0–5% of cells) 
Pattern of invasion Pushing, well 
delineated 
infiltrating borders 
Infiltrating, solid 
cords, 
bands and/or strands 
Small groups or cords 
of infiltrating cells 
Marked and wide-
spread cellular 
dissociation in small 
groups and/or in 
single cells (n < 15) 
Desmoplasia    None Slight Moderate  Marked 
Nuclear 
polymorphism 
Little nuclear 
polymorphism 
(>75% mature cells) 
Moderately abundant 
nuclear polymorphism 
(50–75% mature 
cells) 
Abundant nuclear 
polymorphism 
(25–50% mature 
cells) 
Extreme nuclear 
polymorphism 
(0–25% mature cells) 
Mitotic index (mitoses 
in ten 400x fields) 
0–1 2–3 4-5 >5 
*This grading is a slightly modified version of the Bryne’s system. Scores for each 
parameter provide a score from a minimum of 5 to a maximum score of 20. The tumor 
grade is based on the total score as follows: well-differentiated (5-14), poorly-
differentiated (15-20).  
 
2.2. Immunohistochemistry  
Tissues had been fixed in 10% neutral-buffered formalin for 24 to 48 hours at room 
temperature, processed according to standard procedures, and embedded in paraffin 
wax. Four-micrometer-thick fresh-cut tissue sections on positively charged slides were 
obtained. Immunohistochemical analysis was performed on a BondMax Autostainer 
(Leica, UK). The following monoclonal antibodies were used; anti-COX-2 (clone SP-
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21, 1:50, Thermo, UK), 14-3-3σ (clone 5D7, 1:40, Santa Cruz Biotechnology, 
Germany), PTEN (clone G-6, 1:100, Santa Cruz Biotechnology, Germany), E-cadherin 
(NCH-38, Dako, UK), vimentin (clone V9, 1:500; Dako, UK) and PTEN. Heat-induced 
antigen retrieval was performed using a pH 6 (Bond ER1; Leica, UK) or pH 9 buffer 
(Bond ER2; Leica, UK). The Bond Polymer Refine Detection kit (Leica, UK) was used 
for visualization. A positive reaction was indicated by the presence of distinct brown 
cytoplasmic labelling. As positive control, normal equine glabrous skin (for 14-3-3σ, E-
cadherin, vimentin and PTEN) and normal equine kidney (for COX-2) were used. 
Negative controls were prepared by replacing the primary antibody with Leica Antibody 
Diluent (Leica, UK) only.  
 
2.3. Immunohistochemical evaluation 
Samples were analyzed by two of the authors (ASB and SLP) at a double-headed light 
microscope and discrepancies were discussed and a consensus reached. Analysis 
was made independently of other histopathological features and blinded to clinical 
data. All proteins were semi-quantitatively analyzed in the entire sample in comparison 
with normal penile squamous epithelium by using previously published scoring 
systems for human or veterinary medicine studies. All cell markers were evaluated 
within the tumor core and at the IF. For COX-2, an immunohistochemical score (IHS) 
was assigned based on the intensity of staining (none, 0; weak, 1; moderate, 2; strong, 
3) and percentage of positive tumor cells (0%, 0; <25%, 1; 25-50%, 2; 51-75%, 3; 
>75%, 4) [21]. Positive cells at the tumor surface were excluded from the IHS as they 
were likely reactive/inflamed cells due to surface trauma. The product of the intensity 
and distribution scores gave a total IHS ranging from 0 to 12. For COX-2 and for 
statistical analysis purposes a cut-off value of ≥4 designated a positive case. 14-3-3σ 
cytoplasmic labelling in neoplastic cells was scored based on intensity (none/weak, 1; 
moderate, 2; strong, 3) and percentage of positive tumor cells (<10%, 1; 10-50%, 2; 
>50%, 3). A total IHS from 1 to 9 was obtained by multiplying the values of these two 
parameters. Cases were classified as Low (IHS <9) or High (IHS=9) categories. Any 
labeling of the neoplastic cell nuclei and/or stroma was considered to indicate positive 
14-3-3σ protein expression [15, 17]. PTEN was evaluated following a previously 
published quantification system which used the IHS, 0 (no staining), 1 (weak), 2 
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(medium) and 3 (strong). An IHS of ≤1 designated loss of PTEN [12]. For E-cadherin 
evaluation, cases with ≤ 65% of positive cells with a membranous staining were 
considered negative. For vimentin, cytoplasmic immunoreactivity in more than 5% of 
neoplastic cells designated the tumor as positive [14].  
2.3. Statistical analysis 
Expression of COX-2, 14-3-3σ, E-cadherin and vimentin were compared with 
histological subtype, MI, necrosis, and inflammation. All statistical analysis was 
completed in Graphpad Prism (version 7, GraphPad Software, La Jolla California, 
USA) using a Mann-Whitney U test and/or Spearman’s correlation when appropriate. 
P<0.05 was considered significant for all statistical tests.   
 
3. Results 
3.1. Epidemiological data  
Clinical follow-up was available for 6/45 cases. Four horses, in which excisional 
biopsies or penile amputation were performed, were originally diagnosed as ePSCC. 
In this group three horses were humanely euthanized due to tumor recurrence and 
tumor-related clinical disease (one had lymph node and pulmonary metastasis). The 
mean survival time for these 4 cases was 786 days (187-1178 days). A fifth case was 
originally diagnosed with ePP, recurred two times as ePSCC and died due to gastric 
colic (presumably unrelated to SCC although autopsy was not performed). The sixth 
case, for which follow-up was available, was originally diagnosed as ePP, recurred 
twice as papillomas and is still in remission. Surgical treatment included conventional 
resection plus cryotherapy.  
3.2. Histopathological findings. 
In all cases the tumor cells were compared with those of the normal epidermis to 
characterize their degree of differentiation. Additionally, of the 45 samples, 23 
contained histologically normal epidermis adjacent to the neoplasm. 11/45 (25%) 
penile lesions were classified as ePP. On low power, they were characterized as thick 
plaques or broad-based papillary projections supported by a small amount of 
fibrovascular stroma and frequently orthokeratotic hyperkeratosis was present. A 
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variable degree of superficial erosion (self-induced trauma) with intraepithelial 
neutrophilic exocytosis was observed at the surface of the lesions. At the dermo-
epidermal junction, the basal layer often formed anastomosing rete ridges. Cases of 
papilloma did not invade beyond the basement membrane and the keratinocyte 
maturation was orderly. Benign neoplastic cells had minimal cellular atypia and 
occasionally exhibited a clear and swollen cytoplasm. MI in this group ranged from 1-
30 with a mean value of 8.8 (Fig.1). 
 
 
 
 
 
 
 
Fig. 1. An ePP exhibits multiple papillary projections of acanthotic and dysplastic epidermis radiating 
from a central fibrovascular stalk. 
 
In 34/45 (75%) cases the penile lesions had greater cellular atypia and there was an 
obvious breaching of the basement membrane. These lesions were considered 
malignant and designated as ePSCC. In well-differentiated ePSCC (N=14) the IF 
consisted of broad and anastomosing trabeculae, cords and/or islands supported by 
variable amounts of connective tissue. These later arrangements variably contained 
central accumulations of concentrically laminated keratin (‘keratin pearls’) (Fig.2). A 
scirrhous reaction (desmoplasia) was not observed in well-differentiated ePSCC. 
Anisokaryosis and anisocytosis were mild and the mitotic index ranged from 2-22 with 
a mean value of 9. Some degree of inflammation was observed in almost all well-
differentiated ePSCC consisting mainly of infiltrates of lymphocytes and plasma cells 
with vary rare Mott cells. Only one case exhibited neutrophilic inflammation within the 
supporting stroma.  
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Fig. 2. Formation of a ‘keratin pearl’ in a well-differentiated ePSCC. 
 
Twenty poorly-differentiated ePSCC (N=20) were diagnosed based on the 
histopathological characteristics present at the invasion front (IF). Neoplastic cells at 
the IF were arranged forming irregular trabeculae, nests and clusters of few tumor 
cells which exhibited moderate to marked cellular atypia with no keratinization (Fig. 3). 
A moderate to marked scirrhous reaction was present in all cases at the IF. They 
contained irregularly round nuclei (nuclear pleomorphism) with one or more 
hyperchromatic and prominent nucleoli. Additionally, this group also had nests or 
isolated individual keratinized (dyskeratotic) cells, which consisted of prominent or 
shrunken hypereosinophilic cells with a hyperchromatic nucleus. Moderate to marked 
desmoplasia was observed in all cases within this group. Anisokaryosis and 
anisocytosis were moderate to marked and the MI ranged from 3-66 with a mean value 
of 23. MI was positively correlated with malignancy (ePP vs ePSCC, (p=0.04)) and 
tumor differentiation (well vs poorly differentiated ePSCC, (p=0.001)). Vascular 
invasion (presence of tumoral cells within blood or lymphatic vessels) was observed 
in 7 (20%) poorly-differentiated ePSCC. In two cases of poorly-differentiated ePSCC, 
either lymph node or lung were submitted for histopathological analysis. In both cases, 
tumor metastasis was observed with neoplastic cells displaying the same 
characteristics as the primary tumor (Fig. 4).   
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Fig. 3. Formation of bizarre cords and nests of neoplastic cells in a poorly-differentiated ePSCC.  
 
 
 
 
 
 
 
 
Fig. 4. The lung parenchyma is infiltrated by a metastatic ePSCC. 
 
 
3.3. Immunohistochemical findings  
The main immunohistochemical results are summarized in Table 2. 
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Table 2 
Summary of protein expression results in ePSCC in comparison with known protein expression levels 
in hPSCC and other human carcinomas 
*Up-regulated and down-regulated designation in relation with normal penile tissues 
 
 
3.3.1. COX-2 expression 
Equine kidney exhibited intense immunolabeling of the macula densa that served as 
a positive control for this antibody. Additionally, healthy equine epidermis was always 
negative. When the surface of an ePP or an ePSCC was eroded and inflamed, intense 
labelling was observed but this not assessed to produce an IHS. In this group, 44 
cases were analyzed and 39 (86.6%) were positive and distributed as follows; 10/11 
(90.9%) ePP and 29/33 (87.9%) ePSCC. Total IHS for ePP ranged from 0-6, and 
ePSCC from 0-12 (maximum). The mean IHS was 3.5 for all cases, 2.5 for ePP and 
3.9 for ePSCC. An IHS ≥4 was considered strongly COX-2 positive and ≤3 weakly 
positive (Fig. 5). There was a significant difference between ePP and ePSCC IHS 
(p=0.0003). Mean IHS for well-differentiated ePSCC was 2.4 (range 0-6) and 4.9 
(range 0-12) for poorly-differentiated ePSCC (p=0.033). MI was positively correlated 
with COX-2 expression (p=0.026). 
 
 
 
 
Protein Equine (this study) Human Cell compartment Reference 
COX-2 *Up-regulated in 86.6% Up-regulated in 100%  Cytoplasm 30 
14-3-3σ    Up-regulated in 79% 
 
Down-regulated in 42% 
Up-regulated in 88% (stroma) 
Up-regulated in 61.7%  
Up-regulated in 75%  
Down-regulated in 28% 
Up-regulated in 80% (stroma) 
Nucleus 
Nucleus 
Cytoplasm 
Cytoplasm 
17 
15 
15 
40 
E-cadherin Down-regulated in 64% Down-regulated in 48% 
Down-regulated in 71.8% 
Membrane 
Membrane 
14 
3 
Vimentin Up-regulated in 65% Up-regulated in 33% 
Up-regulated 44% 
Cytoplasm 
Cytoplasm 
14 
3 
PTEN Down-regulated in 50% Down-regulated in 62% Cytoplasm 12 
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Fig.5. Multiple bizarre cords of neoplastic epithelial cells labelling strongly for COX-2 in a poorly-
differentiated ePSCC.  
 
3.3.2. 14-3-3σ expression 
14-3-3σ expression was analyzed in 41 cases: 8 ePP and 33 ePSCC. Keratinocytes 
in all layers of the epidermis exhibited intense cytoplasmic immunolabeling whilst cell 
nuclei were negative. The stratum corneum and subjacent dermal fibroblasts were 
negative in areas of normal epidermis (Fig. 6). Total IHS for both ePP and ePSCC 
ranged from 6-9 (maximum). The mean IHS was 7.9 for all cases, 8.6 for ePP and 7.7 
for ePSCC. An IHS <9 was considered low expression and an IHS of 9 was considered 
high expression. Seven (88%) ePP showed high expression whilst in the ePSCC 
group there was a reduction of the protein in 14 cases (42%). Nuclear immunolabeling, 
detected in 2 ePP (25%) and in 26 ePSCC (79%), was significantly associated with 
malignancy (p=0.0073) but not with tumor grade (r=0.350). Stromal fibroblasts were 
negative in all ePP and positive in 29 ePSCC (88%) cases. No significant difference 
was observed between stromal expression and tumor differentiation. Positive stromal 
fibroblasts were particularly located at the IF while the stroma distant to the IF was 
consistently negative. Additionally, neoplastic cells at the IF largely exhibited 
cytoplasmic and nuclear immunostaining (Fig.7). MI was not correlated with 14-3-3σ 
expression variables. In the metastatic lung lesion, the protein was highly expressed 
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by neoplastic cells but also by adjacent reactive stromal fibroblasts while the remaining 
lung parenchyma was completely negative.  
 
 
 
 
 
 
 
 
Fig. 6. The cytoplasm of normal keratinocytes strongly expresses 14-3-3σ. Cell nuclei are negative. The 
subjacent dermis (star) does not express 14-3-3σ. 
 
 
 
 
 
 
 
Fig. 7. Multiple bizarre cords of neoplastic epithelial cells exhibit slightly weaker cytoplasmic 14-3-3σ 
expression. Cell nuclei are strongly positive. The supportive connective tissue weakly expresses 14-3-
3σ protein. Inset: An area of connective tissue away from the invasion front of the same case is 
completely negative. 
 
 
 
 
14 
 
3.3.3. E-cadherin expression 
E-cadherin expression was assessed in 43 samples: 10 ePP and 33 ePSCC. Normal 
epidermis and all ePP samples displayed the same staining intensity as the cell 
membrane (Fig. 8). Conversely, 21 (63.6%) ePSCC showed significantly decreased 
(downregulation) E-cadherin labelling (p=0.0005) (Fig. 9). Downregulation was also 
significantly associated with poorly-differentiated ePSCC (p=0.027). Additionally, 27 
(81.8%) ePSCC exhibited abnormal cytoplasmic expression with 7 (21.1%) having lost 
all typical membranous expression (p=<0.0001). Furthermore, this was correlated with 
histological differentiation: all poorly-differentiated ePSCC exhibited cytoplasmic 
expression compared to only 7/13 (53.8%) well-differentiated tumors (p=0.002). A 
negative correlation between E-cadherin expression and MI was noted (p=0.0022), in 
addition to a positive correlation between MI and atypical distribution of labelling 
(p=0.0017). A positive correlation between cytoplasmic E-cadherin translocation and 
nuclear 14-3-3σ expression was detected (p=0.0008).  
 
 
 
 
 
 
 
 
Fig. 8. E-cadherin antibody uniformly highlights the normal penile epidermis. The subjacent stroma is 
negative. 
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Fig. 9. Multiple bizarre cords of neoplastic epithelial cells show loss of E-cadherin expression in a poorly-
differentiated ePSCC. Inset: Neoplastic cells exhibit cytoplasmic E-cadherin. 
 
3.3.4 Vimentin expression  
Vimentin expression was assessed in 41 cases. In normal skin, ePP and well-
differentiated ePSCC this antibody highlighted mesenchymal components of the 
dermis (blood vessels, fibrocytes, adipocytes, mononuclear inflammatory cells) whilst 
the epithelial cells were consistently negative. In 13 out of 20 poorly-differentiated 
ePSCC (65%) vimentin was expressed in more than 10% of neoplastic cells at the IF 
and was statistically associated with malignancy (p=0.0001) and with tumor 
differentiation (p<0.0001) (Fig.10). Groups of neoplastic cells within lymph node and 
lung metastases neo-expressed vimentin intermediate filaments. Vimentin 
neoexpression was correlated with decreased expression of E-cadherin and but not 
with E-cadherin nuclear expression. No other significant correlations with the 
remaining markers were observed.  
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Fig. 10. Multiple nests of neoplastic epithelial cells labelling strongly for vimentin in a poorly-
differentiated ePSCC. Fibroblasts within the supporting stroma are also positive.     
 
3.3.4. PTEN expression  
A subset of 4 ePP, 2 well- and 2 poorly-differentiated ePSCC were analyzed. In areas 
of histologically normal skin, as well as in the four ePP, PTEN was present in the 
cytoplasm of keratinocytes and variably in fibroblasts. The canine mammary gland 
used as positive control stained appropriately. The 2 well-differentiated ePSCC 
showed areas of medium or weak immunoreaction while the 2 poorly-differentiated 
ePSCC were negative (Fig. 11 and Fig. 12).  
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Fig. 11. PTEN is expressed by keratinocytes in an ePP. Fibroblasts within the subjacent dermis are 
moderately positive.  
 
 
 
 
 
 
 
 
Fig. 12. Multiple bizarre cords of neoplastic epithelial cells show total loss of PTEN expression in a 
poorly-differentiated ePSCC. 
 
4. Discussion 
Around 10% of all neoplasms in the horse affect the external genitalia and ePSCC is 
the most common with a reported incidence of 50-83% which greatly exceeds the 
incidence of this cancer in humans [22-24]. In both humans and horses the disease 
produces severe discomfort, spreads to regional lymph nodes leading to distant 
metastases and death. In humans its low incidence and the lack of a reliable inducible 
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animal model has limited significant breakthroughs regarding pathogenesis and 
potential therapeutic targets [2, 7, 22, 25]. In this study we have analyzed histologically 
and immunohistochemically 45 cases of ePSCC to investigate the expression of 
cancer-related proteins and correlated them with the histomorphological features of 
these tumors. Furthermore, this study aimed to analyze, for the first time, the 
occurrence of EMT at the IF of ePSCC as has been documented in hPSCC [3, 13, 
14].  
Histological examination identified 11 ePP and 34 ePSCC. In the latter group a two-
tier grading system of the IF identified 14 well-differentiated and 20 poorly-
differentiated ePSCC. The histological appearance of ePP resembles the human 
‘differentiated’ and ‘warty’ subtypes of penile intraepithelial neoplasia (PeIN) and 
ePSCC is virtually identical to the most common subtype of PSCC termed ‘usual type’ 
[4, 26]. The new WHO classification for epithelial penile tumors is based on both 
morphological features and immunoreactivity of the biopsy sample for p16 HPV [5, 
26]. Although there is recent evidence that EcPV-2 is integrated in the host genome in 
approximately 20-40% of SCC, a similar classification system, based on morphology 
and EcPV-2-status, has not been established for horses [19, 27]. This is probably due, 
in part, to the lack of a commercially available anti-EcPV-2 antibody but other potential 
limitations such as laboratory costs and reticence of owners may be involved. Future 
multi-institutional studies in a large cohort of samples should focus on addressing a 
possible association between EcPV-2 infection status and histomorphological variants 
not yet described.  
Overexpression of COX-2 in different types of carcinomas in humans and domestic 
animals is associated with an anti-apoptotic, pro-angiogenic, invasive and metastatic 
phenotype. Regarding ePSCC, this study is the largest to significantly associate COX-
2 expression with malignancy, tumor differentiation and MI, all important prognostic 
factors for survival and metastasis. In the present study 86% of the examined cases 
exhibited COX-2 immunoreaction which is in agreement with a previous study [28], but 
differs from another that reported only 50% of cases being positive with the majority 
showing less than 1% of immunoreactive neoplastic cells [21]. In these studies, 
correlation between COX-2 overexpression, tumor differentiation and MI was not 
analyzed or showed no statistical association. A third study using Western-Blot found 
ubiquitous COX-2 expression in both normal epidermis and ePSCC samples [29]. This 
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variability of results could be attributed to differences in methodology, antibodies, 
different thresholds employed or unknown pre-sampling treatment using non-steroidal 
anti-inflammatory drugs (NSAIDs). Interestingly, our study shows that ePSCCs 
overexpress COX-2 in a high proportion of cases as occurs in invasive hPSCC but 
also esophageal SCC [30, 31]. The use of COX-2 inhibitors alone or as part of a 
multimodal therapy to aid in the treatment of the disease is a field of current research 
in human and veterinary medicine [10, 11, 32]. To illustrate this, in veterinary medicine 
NSAIDs are routinely used in the adjunct treatment of canine urothelial carcinomas, a 
well-recognized spontaneous model for human bladder cancer [33]. Furthermore, a 
single case reported complete remission of an equine head and neck carcinoma with 
anti-COX-2 therapy [34]. Given that in humans, inhibition of COX-2 as part of the 
therapeutic plan is currently under debate, we propose that the horse could represent 
a reliable and accessible spontaneous model to test novel COX-2 selective inhibitors 
to treat this type of cancer.  
In various human carcinomas, including those of the head and neck, cervical and 
vulvar carcinomas, altered 14-3-3σ expression is associated with greater 
invasiveness, proliferation and metastasis [15, 17, 35]. Furthermore, in canine 
inflammatory mammary carcinoma, a very aggressive type of carcinoma that 
resembles inflammatory breast carcinoma in women, and in canine renal cell 
carcinomas, there is a significant neo-expression of 14-3-3σ protein and it is an 
independent prognostic indicator of shorter survival time [36, 37]. Expression of 14-3-
3σ in tumoral cells is usually cytoplasmic, however in very aggressive neoplasms 
nuclear translocation can occur and is associated with cell proliferation. In normal 
conditions, 14-3-3σ sequesters CDK2/cyclin B1 in the cytoplasm resulting in G/M2 
arrest. Consequently, 14-3-3σ nuclear translocation could play a role in the 
progression of SCC. Interestingly, in our study none of the samples of normal 
epidermis showed nuclear 14-3-3σ expression whilst the opposite was true in 80% 
ePSCC. Similar results have been published in human esophageal and vulvar SCC 
[16, 17]. 14-3-3σ was originally identified as an epithelial marker constitutively 
expressed in various types of epithelium. On the other hand, several studies have 
demonstrated that 14-3-3σ is secreted into the extracellular milieu by keratinocytes 
and induces fibroblasts to produce and secrete matrix metalloproteinases which allow 
the tumor to invade and metastasize [38, 39]. Recently stromal expression of 14-3-3σ 
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has been demonstrated in endometrial carcinomas and, similar to our results, the 
neoexpression by fibroblasts in areas of desmoplasia at the IF could be indicative of 
an active proinvasive environment within the extracellular matrix [40]. To provide more 
evidence of the role of 14-3-3σ in cancer development, recently it has been shown 
that 14-3-3σ provides chemoresistance properties to SCC and this fact, along with the 
anti-apoptotic properties of 14-3-3σ in tumoral cells, highlights the potential of this 
protein as a very promising biomarker and therapeutic target for penile SCC [18, 41-
43].   
PTEN expression could only be analyzed in a small subset of benign and malignant 
penile lesions. We observed a complete absence of this tumor suppressor protein in 
poorly-differentiated ePSCC whilst areas of normal epidermis, ePP and well-
differentiated ePSCC were all variably positive. Obviously the sample size is too small 
to draw any conclusion regarding the role of PTEN in ePSCC, however based on our 
results we suggest a loss of PTEN tumor suppressor protein in a similar way as occurs 
in human PSCC [12].   
In order to suggest a particular naturally-occurring neoplasm in a companion animal 
species, as a reliable model to study its human counterpart, the neoplasm should 
closely mimic the hallmarks of multistep cancer development which include; a similar 
initiator agent, the capacity to evade anti-proliferative signals, the production of anti-
apoptotic and pro-proliferative proteins, the activation of angiogenesis, and the 
acquisition of pro-invasive and metastatic abilities. Metastasis is the main complication 
and cause of death in human patients with advanced hPSCC and horses with 
advanced disease are humanely euthanized to avoid suffering. Recently a number of 
publications have studied the occurrence of the EMT phenotype in hPSCC [3, 13, 14]. 
EMT is a complex process that involves the loss of epithelial characteristics, which 
includes E-cadherin downregulation, and the acquisition of a mesenchymal 
phenotype, mainly vimentin neoexpression. EMT is a normal and essentially 
physiologic event during embryogenesis and wound healing but in cancer is directly 
associated with apoptosis resistance, stromal and lymphovascular invasion, 
metastasis and poor prognosis [44]. To the authors’ knowledge this is the first study 
to analyze the EMT process in an equine cancer, and provides evidence of dramatic 
E-cadherin downregulation and significant vimentin neoexpression, the latter a 
canonical marker of EMT, which was found in 65% of poorly-differentiated ePSCC. 
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Neoplastic cells neoexpressing vimentin had very low or absence of membranous E-
cadherin or, interestingly, they exhibited cytoplasmic internalization of the protein. 
Aberrant cytoplasmic and nuclear E-cadherin expression has been recently related 
with a more aggressive behavior in cancer due to increasing signaling through 
activation of AKT/MAPK pathways via PI3K interaction [45, 46]. Additionally, we 
observed that neoplastic cells neo-expressing vimentin highly expressed 14-3-3σ. Our 
findings are in agreement with previous investigations that showed co-expression of 
14-3-3σ and vimentin in EMT areas at the IF and the formation of a 14-3-3σ-vimentin 
complex that inhibits autophagy via an AKT-dependent mechanism, consequently 
promoting cell survival in cancerous cells [47, 48].  
 
5. Conclusions 
In summary, our study is the first to recognize the histological and 
immunophenotypical similarities between ePSCC and hPSCC. Additionally, we have 
demonstrated that when the IF exhibits features of a poorly-differentiated PSCC, EMT 
is a usual event. In light of these findings and in the era of the ‘one-pathology’ concept, 
we suggest that further research comparing equine and human PSCC could represent 
an outstanding opportunity to develop a preclinical animal model from which both 
species could obtain substantial benefit.   
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